Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd.

About Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd.

Founded in 2013, Nanjing Heron Pharmaceutical Science & Technology Company Limited is an innovation-oriented company engaged in the research, development and industrial production of new drugs and first-time generic drugs in China. Active Vitamin D derivatives synthesis and Regulatory Service with Technical Support are the two critical characteristics of Heron Pharma. In 2016, Heron Pharma successfully landed on the NEEQ Stock market (National Equities Exchange and Quotations, Stock Code: 870070). We established a GMP-certified production site for the scale-up and industrial production of APIs, SODFs, soft gel capsule, small volume injections and topical dosage forms. In 2018, an Accreditation Certificate of Foreign Drug Manufacturer was certified to Heron’s manufacturing base by Japan Pharmaceutical and Medical Devices Agency (PMDA, No. AG10500666).

Heron (Shanghai) Pharmaceutical Science and Technology Co., Ltd. is a holding company of Nanjing Heron Pharma responsible for the export business of full range vi...

  • CN
  • 2019
    On CPhI since
Contact info

Products from Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd.

  • Calcitriol

    Product Calcitriol

    Calcitriol (骨化三醇)  in compliance with BP/USP/EP monographs, produced under GMP conditions, indicated for Rickets, Osteoporosis, Hypoparathyroidism, Renal osteodystrophy and Osteomalacia.
  • Alfacalcidol

    Product Alfacalcidol

    Alfacalcidol (阿法骨化醇) is in compliance with the monographs of EP/BP/ChP Grade, produced under GMP conditions and indicated for Osteoporosis, Chronic renal insufficiency, Hypoparathyroidism, Vitamin D-resistant rickets and Osteomalacia.
  • Tacalcitol Monohydrate

    Product Tacalcitol Monohydrate

    in compliance with the monographs of EP/JP, produced under GMP conditions and indicated for Psoriasis Vulgaris
  • Doxercalciferol

    Product Doxercalciferol

    in compliance with Monograph of USP, produced under GMP conditions and indicated for Secondary hyperparathyroidism
  • Calcipotriol monohydrate

    Product Calcipotriol monohydrate

    EP/BP Grade, produced under GMP conditions, indicated for Psoriasis Vulgaris.
  • Eldecalcitol

    Product Eldecalcitol

    Produced under GMP conditions, indicated for Osteoporosis
  • Paricalcitol

    Product Paricalcitol

     USP grade, produced under GMP conditions and indicated for Secondary hyperparathyroidism
  • Maxacalcitol

    Product Maxacalcitol

    produced under GMP conditions, indicated for Secondary hyperparathyroidism and Psoriasis
  • Calcifediol

    Product Calcifediol

    in compliance with the monographs of USP/EP/BP, produced under GMP conditions, indicated for Osteoporosis, Rickets and Osteomalacia.
  • Dexlansoprazole Sodium

    Product Dexlansoprazole Sodium

    produced under GMP conditions, indicated for Gastric ulcer, duodenal ulcer and reflux esophagitis
  • Bisacodyl

    Product Bisacodyl

    ChP Grade, produced under GMP conditions with China Drug License
  • Nonoxynol

    Product Nonoxynol

    ChP/EP grade, produced under GMP conditions with China's Drug License

Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd. Resources